🇺🇸 FDA
Patent

US 10208016

1-sulfonyl piperidine derivatives as modulators of prokineticin receptors

granted A61KA61K31/454A61P

Quick answer

US patent 10208016 (1-sulfonyl piperidine derivatives as modulators of prokineticin receptors) held by Takeda Pharmaceutical Company Limited expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/454, A61P, A61P25/00, A61P25/04